rfa-dp-14-01102pphf15 final 7 22 15.docx

Office of Grants Services (OGS)

PPHF Continuation Guidance

Centers for Disease Control and Prevention (CDC) Procurement and Grants Office Instructions for Preparing an Annual Performance Report Financed in Part by Prevention and Public Health Fund (PPHF) Catalog of Federal Domestic Assistance (CFDA): 93.542 Funding Opportunity Announcement FOA Number

RFA-DP-14-01102PPHF15

PPHF2015: Nutrition, Physical Activity & Obesity Base Activities –Health Promotion and Disease Prevention Research Centers: Special Interest Project – financed in part by 2015 Prevention and Public Health Funds

Eligibility:

This FOA is financed in part by fiscal year 2015 Prevention and Public Health Fund (PPHF) and is a continuation of funds intended only for grantees previously awarded under CDC-RFA-DP14-011, entitled “Health Promotion and Disease Prevention Research Centers; Special Interest Projects.”

Application Submission:

This announcement does not solicit applications. Selections will be made based on applications previously received.

The Interim Progress Report/Non-Competing Continuation application should provide a progress and performance report for activities of the current budget period and describe the objectives and activities to be undertaken during the new budget period. The application should be prepared using the PHS 2590 Non-Competing Grant Progress Report. Following are specific instructions for using the PHS 2590 to prepare progress reports for submission to the Centers for Disease Control and Prevention (CDC).

Complete the forms following the specific instructions in Section II: Preparing Your Progress Report (forms can be downloaded in either PDF or MS Word at http://grants1.nih.gov/grants/funding/2590/2590.htm).

The Interim Progress Report/Non-Competing Continuation application must contain the following elements:

Progress toward major goals and objectives of the Core Research project and the SIP(s):

Specific aims – describe the specific aims of the project.

Studies and results – describe your progress in the following areas indicated below directed toward specific aims during the current budget year and the results obtained, negative results should also be included. If significant problems were encountered, describe how your approach was modified.

Significance – provide a description of the significance of the overall activities from your site to the scientific field and the potential impact on public health. Describe recent findings, i.e., those occurring during this project period, and explain how these efforts demonstrate progress toward the overall study goals and objectives and how the study is contributing to the achievement of the funding opportunity announcement (FOA) published purpose and intent. Include major milestones and accomplishments.

Publications and other Research Products – provide one copy of each product of research such as, but not limited to, peer reviewed publications, other publications and reports, tools, protocols, press releases, other dissemination materials, national or international guidelines, presentations at research or scientific meetings, conferences, or forums.

List all publications and other research products on a separate sheet of paper. The list should be cumulative (from budget period to budget period)

Report only those products of research directly related to this grant. State if there have been no products or publications.

Significant barriers encountered and resulting project changes:

Barriers and significant changes - if there have been any new or significant changes in the study aims, budget, scope of activities, operational methods, evaluation, time delays, etc. explain and justify. If proposed project aims are different from current funded aims, please list the revised aims and the reason for the modification. If unchanged, please state. Describe any technical or other problems and solutions to overcome the problem.

Project operations – provide a description of any actual or planned changes to project operations from the current year and the reasons for the changes. Some examples of changes in project operations include change in: case ascertainment, interviewer or coding organization, the location or processing of biologic specimens, laboratory processes for quality assurance, etc.

Plans for upcoming year:

Plans – describe plans to address the specific aims during the next year of support.

Site Visits – Please ensure the Interim Progress Report/Non-competing continuation application addresses any weaknesses and recommendations noted during site visits or other meetings conducted in the past year.

Human subject’s assurance:

Human subjects – indicate “no change” on the summary page if the protocols planned for the coming year are not different from last year’s submission. Indicate “change” if the protocols are different from those proposed in the previous submission. Please provide/attach proof of IRB approval to involve human subjects in research for all performing sites. Provide detailed Human subjects Research information for human subject studies planned for the upcoming year that were identified in the Research Plan of the initial application but were not adequately described because they were planned for a later time within the project period.

Reporting data on inclusion – if you are conducting clinical research, you must report the annual cumulative enrollment of subjects and their distribution by sex/gender and ethnicity/race, unless otherwise notified by your program official. If there are changes from the targeted/planned enrollment originally approved for funding, you should submit a revised Target/Planned Enrollment page.

Human subjects education requirement – for cooperative agreements involving human subjects, provide certification for any new key personnel or other significant contributors involved in the design or conduct of research involving human subjects that they have completed an educational program in the protection of human subjects.

Budget:

Provide a detailed budget and justification, itemizing the direct costs requested for the next budget period by budget categories. Refer to the Terms and Conditions of your current Notice of Award for allowable and non-allowable costs. Also, refer to the CDC Budget Guidelines for instructions on preparing the budget.

If you anticipate an estimated unobligated balance greater than 25 percent of the current year’s total budget, please provide the estimated dollar amount and provide an explanation including why there is a significant balance and how it will be spent (budget and justification, and work plan) if carried forward into the next budget period. If no balance is anticipated, please state, “no balance anticipated.”

Application instructions and attachments:

Number all pages consecutively and print on one side only. Do not staple and/or bind your application. The Progress Report Summary should not exceed 20 pages.

Include all Federal Wide Assurances (FWA) and IRB approval letter(s) to involve human subjects in research. If assurances have expired, and updated letters are not provided, a restriction will be placed on the award, pending receipt of approval letter(s).

Provide a copy of your organization’s current Federal negotiated indirect cost rate agreement.

Reporting:

Federal Financial Report (FFR) is due 90 days after the end of a calendar quarter during which the budget period ended.

Application submission:

Submission Instructions and Deadline Date - Do not mail progress reports to the centralized mailing address listed in Section 1 of the instructions

CDC must receive the signed original and two copies of the application, via mail, on or before March 30, 2015.

A late or incomplete package may result in an enforcement action such as a delay in the awards.

CDC will only accept requests for a deadline extension on rare occasions and only after adequate justification has been provided.

Please submit your report to:

Centers for Disease Control and Prevention (CDC) Procurement and Grants Office Attn: Daryl Barksdale Grants Management Specialist 2920 Brandywine Road, Room 3000, Mailstop E-09 Atlanta, GA. 30341

Please also submit a courtesy copy of your application, via email, to the following address:

ARTB@cdc.gov

**Reference your cooperative agreement number on all correspondence.

If you have any grants management questions, including questions related to the budget, please contact Daryl Barksdale, Grants Management Specialist at 770-488-1087 or email address xxj8@cdc.gov.

For additional programmatic information, please contact Donna Henry, NCCDPHP, Division of Public Health, Applied Research & Translation Branch Prevention Research Centers Program Phone: 770-488-2462 Email: ijw8@cdc.gov

PPHF Grantees Semi-annual Reporting CDC-OCOO-BISM will distribute the pre-populated reporting templates to PPHF Grantees through the BISM mailbox (BISMPPHF@cdc.gov). All recipients will receive their pre-populated template prior to the start of the reporting period with additional guidance. CDC will validate grantee email addresses through the Procurement and Grants Office and PPHF programs. The prime grantee will receive the report and will be responsible for populating the sub-award information.

Estimated Funding:

FY15 PPHF funding will be $2,295,895 Total FY15 funds including PPHF funds will be $10,092,486 Office of Grants Services (OGS) image1.png image2.png